Penumbra Inc (0P8 STU) stock market data APIs
€223.3573
8.05(3.6%)
as of September 15, 2025
Try our APIs with
free plan!
Penumbra Inc Financial Data Overview
Price chart is built with
Anychart
Prev. Close
223.3573
Open
231.4038
High
233.5176
Low
223.3573
52 wk Range
166.25-294
Market Cap
8 103 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Penumbra Inc data using free add-ons & libraries
Get Penumbra Inc Fundamental Data
Penumbra Inc Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Penumbra Inc News
New
Dow Jones Leader Verizon Eyes Buy Point; Netflix Breaks Out On Earnings
Dow Jones stock Verizon is near a new buy point, while Netflix stock is breaking out past an entry on earnings. Continue Reading View Comments
Stroke Management Drug Firm Climbs To Key Level Ahead Of Earnings; But Beware This Pharma Tariff
Penumbra is hovering near its 50-day moving average within a consolidation base that has a buy point of 310. On the weekly chart on Investor's Business Daily's MarketSurge, the stock shows a blue dot ...
What To Expect From Penumbra’s (PEN) Q1 Earnings
Medical device company Penumbra (NYSE:PEN) will be reporting results tomorrow after the bell. Here’s what investors should know. Penumbra beat analysts’ revenue expectations by 1.2% last quarter,...
Why Penumbra (PEN) is Poised to Beat Earnings Estimates Again
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Penumbra (PEN), which belongs to the Zacks Medica...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
